Therapeutic Potential of Mesenchymal Stem Cells for Oral and Systemic Diseases

Dental Clinics of North America

Volumn 56, Issue 3, 2012, Pages 651-675

  Kim, Reuben H ^a   Mehrazarin, Shebli ^a   Kang, Mo K ^a  

^a UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

Epithelial mesenchymal transition; Immunosuppression; Mesenchymal stem cells; Pulp capping; Pulp revitalization; Tissue engineering

Indexed keywords

AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; DENTITION; ENDODONTICS; HUMAN; MESENCHYMAL STROMA CELL; METHODOLOGY; MOUTH DISEASE; PHYSIOLOGY; REGENERATIVE MEDICINE; REVIEW; SKIN DISEASE; TISSUE ENGINEERING;

AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; DENTAL PULP CAPPING; DENTITION; HUMANS; MESENCHYMAL STROMAL CELLS; MOUTH DISEASES; REGENERATIVE MEDICINE; SKIN DISEASES; TISSUE ENGINEERING;

EID: 84864321355     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2012.05.006     Document Type: Review

References (144)

1. Kode J.A., Mukherjee S., Joglekar M.V., et al. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 2009, 11:377-391.
2. Friedenstein A.J., Piatetzky-Shapiro I., Petrakova K.V. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966, 16:381-390.
3. Gronthos S., Mankani M., Brahim J., et al. Postnatal human dental pulp stem cells (DPSCs). Proc Natl Acad Sci U S A 2000, 97:13625-13630.
4. Yang S., Huang S., Feng C., et al. Umbilical cord-derived mesenchymal stem cells: strategies, challenges, and potential for cutaneous regeneration. Front Med 2012, 6:41-47.
5. Gonzalez R.E., Gonzalez M.A., Varela N., et al. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis 2010, 69:241-248.
6. Nowak J.A., Polak L., Pasolli H.A., et al. Hair follicle stem cells are specified and function in early skin morphogenesis. Cell Stem Cell 2008, 3:33-43.
7. Sonoyama W., Liu Y., Fang D., et al. Mesenchymal stem cell mediated functional tooth regeneration in swine. PLoS One 2006, 1:e79.
8. Seo B.M., Miura M., Gronthos S., et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004, 364:149-155.
9. Miura M., Gronthos S., Zhao M., et al. SHED: stem cells from human exfoliated teeth. Proc Natl Acad Sci U S A 2003, 100:5807-5812.
10. Yao S., Pan F., Pripic V., et al. Differentiation of stem cells in the dental follicle. J Dent Res 2008, 87:767-771.
11. Huang G.T., Gronthos S., Shi S. Mesenchymal stem cells derived from dental tissues vs. those derived from other sources: their biology and role in regenerative medicine. J Dent Res 2009, 88:792-806.
12. Oh J.E., Kim R.H., Shin K.H., et al. DeltaNp63α protein triggers epithelial-mesenchymal transition and confers stem cell properties in normal human keratinocytes. J Biol Chem 2011, 286:38757-38767.
13. Mehrazarin S., Oh J.E., Chung C.L., et al. Impaired odontogenic differentiation of senescent dental mesenchymal stem cells is associated with loss of Bmi-1 expression. J Endod 2011, 37:662-666.
14. Gronthos S., Graves S.E., Ohta S., et al. The STRO-1 fraction of adult human bone marrow contains osteogenic precursors. Blood 1994, 84:4164-4173.
15. Wagner W., Horn P., Castoldi M., et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 2008, 3:e2213.
16. Hoogduijn M.J., Popp F., Verbeek R., et al. The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. Int Immunopharmacol 2010, 10:1496-1500.
17. Pevsner-Fischer M., Morad V., Cohen-Sfady M., et al. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 2007, 109:1422-1432.
18. Tomchuck S.L., Zwezdaryk K.J., Coffelt S.B., et al. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 2008, 26:99-107.
19. Spaggiari G.M., Capobianco A., Abdelrazik H., et al. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 2008, 111:1327-1333.
20. Pierdomenico L., Bonsi L., Calvitti M., et al. Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation 2005, 80:836-842.
21. Tomic S., Djokic J., Vasilijic S., et al. Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by Toll-like receptor agonists. Stem Cells Dev 2011, 20:695-708.
22. Castagnola L., Orlay H.G. Direct capping of the pulp and vital amputation. Br Dent J 1950, 88:324-330.
23. Auschill T.M., Arweiler N.B., Hellwig E., et al. Success rate of direct pulp capping with calcium hydroxide. Schweiz Monatsschr Zahnmed 2003, 113:946-952.
24. Mente J., Geletneky B., Ohle M., et al. Mineral trioxide aggregate or calcium hydroxide direct pulp capping: an analysis of the clinical treatment outcome. J Endod 2010, 36:806-813.
25. Farsi N., Alamoudi N., Balto K., et al. Clinical assessment of mineral trioxide aggregate (MTA) as direct pulp capping in young permanent teeth. J Clin Pediatr Dent 2006, 31:72-76.
26. Bogen G., Kim J.S., Bakland L.K. Direct pulp capping with mineral trioxide aggregate: an observational study. J Am Dent Assoc 2008, 139:305-315.
27. Cvek M. Treatment of non-vital permanent incisors with calcium hydroxide. IV. Periodontal healing and closure of the root canal in the coronal fragment of teeth with intra-alveolar fracture and vital apical fragment. A follow-up. Odontol Revy 1974, 25:239-246.
28. Cox C.F., Subay R.K., Ostro E., et al. Tunnel defects in dentin bridges: their formation following direct pulp capping. Oper Dent 1996, 21:4-11.
29. Banchs F., Trope M. Revascularization of immature permanent teeth with apical periodontitis: new treatment protocol?. J Endod 2004, 30:196-200.
30. Chueh L.H., Ho Y.C., Kuo T.C., et al. Regenerative endodontic treatment for necrotic immature permanent teeth. J Endod 2009, 35:160-164.
31. Cehreli Z.C., Isbitiren B., Sara S., et al. Regenerative endodontic treatment (revascularization) of immature necrotic molars medicated with calcium hydroxide: a case series. J Endod 2011, 37:1327-1330.
32. Torabinejad M., Turman M. Revitalization of tooth with necrotic pulp and open apex by using platelet-rich plasma: a case report. J Endod 2011, 37:265-268.
33. Bose R., Nummikoski R., Hargreaves K.M. A retrospective evaluation of radiographic outcomes in immature teeth with necrotic root canal systems treated with regenerative endodontic procedures. J Endod 2009, 35:1343-1349.
34. Lovelace T.W., Henry M.A., Hargreaves K.M., et al. Evaluation of the delivery of mesenchymal stem cells into the root canal space of necrotic immature teeth after clinical regenerative endodontic procedure. J Endod 2011, 37:133-138.
35. Li Y., Lu X., Sun X., et al. Odontoblast-like cell differentiation and dentin formation induced with TGF-β1. Arch Oral Biol 2011, 56:1221-1229.
36. Suzuki T., Lee C.H., Chen M., et al. Induced migration of dental pulp stem cells for in vivo pulp regeneration. J Dent Res 2011, 90:1013-1018.
37. Yang X., Han G., Fan M. Chitosan/collagen scaffold containing bone morphogenetic protein-7 DNA supports dental pulp stem cell differentiation in vitro and in vivo. J Biomed Mater Res 2012, [Epub ahead of print].
38. Imura N., Pinheiro E.T., Gomes B.P., et al. The outcome of endodontic treatment: a retrospective study of 2000 cases performed by a specialist. J Endod 2007, 33:1278-1282.
39. Hannahan J.P., Eleazer P.D. Comparison of success of implants versus endodontically treated teeth. J Endod 2008, 34:1302-1305.
40. Vire D.E. Failure of endodontically treated teeth: classification and evaluation. J Endod 1991, 17:338-342.
41. Sedgley C.M., Messer H.H. Are endodontically treated teeth more brittle?. J Endod 1992, 18:332-335.
42. Huang G.T.J., Yamaza T., Shea L.D., et al. Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model. Tissue Eng 2010, 16:605-615.
43. Sakai V.T., Cordeiro M.M., Dong Z., et al. Tooth slice/scaffold model of dental pulp tissue engineering. Adv Dent Res 2011, 23:325-332.
44. Donaldson M., Kinirons M.J. Factors affecting the time of onset of resorption in avulsed and replanted incisor teeth in children. Dent Traumatol 2001, 17:205-209.
45. Dangaria S.J., Ito Y., Luan X., et al. Successful periodontal ligament regeneration by periodontal progenitor preceding on natural tooth root surfaces. Stem Cells Dev 2011, 20:1659-1668.
46. Lin Y., Gallucci G.O., Buser D., et al. Bioengineered periodontal tissue formed on titanium dental implants. J Dent Res 2011, 90:251-256.
47. Gault P., Black A., Romette J.L., et al. Tissue-engineered ligament: implant constructs for tooth replacement. J Clin Periodontol 2010, 37:750-758.
48. Lineen E., Namias N. Biologic dressing in burns. J Craniofac Surg 2008, 19:923-928.
49. Heimbach D.M., Warden G.D., Luterman A., et al. Multicenter postapproval clinical trial of Integra dermal regeneration template for burn treatment. J Burn Care Rehabil 2003, 24:42-48.
50. Badiavas E.V., Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 2003, 139:510-516.
51. Badiavas E.V., Ford D., Liu P., et al. Long-term bone marrow culture and its clinical potential in chronic wound healing. Wound Repair Regen 2007, 15:856-865.
52. Lataillade J.J., Doucet C., Bey E., et al. New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med 2007, 2:785-794.
53. Ichioka S., Kouraba S., Sekiya N., et al. Bone marrow-impregnated collagen matrix for wound healing: experimental evaluation in a microcirculatory model of angiogenesis, and clinical experience. Br J Plast Surg 2005, 58:1124-1130.
54. Yoshikawa T., Mitsuno H., Nonaka I., et al. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg 2008, 121:860-877.
55. Garcia-Olmo D., Herreros D., Pascual I., et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 2009, 52:79-86.
56. Guadalajara H., Herreros D., De-La-Quintana P., et al. Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int J Colorectal Dis 2012, 27(5):595-600.
57. Fujita Y., Inokuma D., Abe R., et al. Conversion from human haematopoietic stem cells to keratinocytes requires keratinocyte secretory factors. Clin Exp Dermatol 2012, [Epub ahead of print].
58. Wu Y., Chen L., Scott P.G., et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007, 25:2648-2659.
59. Sun Y., Weber K.T. Infarct scar: a dynamic tissue. Cardiovasc Res 2000, 46:250-256.
60. Fukuda K. Molecular characterization of regenerated cardiomyocytes derived from adult mesenchymal stem cells. Congenit Anom 2002, 42:1-9.
61. Makino S., Fukuda K., Miyoshi S., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999, 103:697-705.
62. Shim W.S., Jiang S., Wong P., et al. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun 2004, 324:481-488.
63. Miyahara Y., Nagaya N., Kataoka M., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006, 12:459-465.
64. Amado L.C., Saliaris A.P., Schuleri K.H., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 2005, 102:11474-11479.
65. Fazel S., Chen L., Weisel R.D., et al. Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor. J Thorac Cardiovasc Surg 2005, 130:1310.
66. Sun L., Zhang T., Lan X., et al. Effects of stem cell therapy on left ventricular remodeling after acute myocardial infarction: a meta-analysis. Clin Cardiol 2010, 33:296-302.
67. Trounson A., Thakar R.G., Lomax G., et al. Clinical trials for stem cell therapies. BMC Med 2011, 9:52.
68. Lasala G.P., Silva J.A., Kusnick B.A., et al. Combination stem cell therapy for the treatment of medically refractory coronary ischemia: a phase I study. Cardiovasc Revasc Med 2011, 12:29-34.
69. Robertson R.P., Sutherland D.E., Kendall D.M., et al. Metabolic characterization of long-term successful pancreas transplants in type I diabetes. J Investig Med 1996, 44:549-555.
70. Tang D.Q., Cao L.Z., Burkhardt B.R., et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 2004, 53:1721-1732.
71. Choi K.S., Shin J.S., Lee J.J., et al. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun 2005, 330:1299-1305.
72. Moriscot C., de Fraipont F., Richard M.J., et al. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells 2005, 23:594-603.
73. Karnieli O., Izhar-Prato Y., Bulvik S., et al. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 2007, 25:2837-2844.
74. Sun Y., Chen L., Hou X.G. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin Med J 2007, 120:771-776.
75. Kim S.J., Choi Y.S., Ko E.S., et al. Glucose-stimulated insulin secretion of various mesenchymal stem cells after insulin-producing cell differentiation. J Biosci Bioeng 2012, 113(6):771-777.
76. Ianus A., Holz G.G., Theise N.D., et al. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003, 111:843-850.
77. Choi J.B., Uchino H., Azuma K., et al. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia 2003, 46:1366-1374.
78. Hess D., Li L., Martin M., et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003, 21:763-770.
79. Chivu M., Dima S.O., Stancu C.I., et al. In vitro hepatic differentiation of human bone marrow mesenchymal stem cells under differential exposure to liver-specific factors. Transl Res 2009, 154:122-132.
80. Dong X.J., Zhang G.R., Zhou Q.J., et al. Direct hepatic differentiation of mouse embryonic stem cells induced by valproic acid and cytokines. World J Gastroenterol 2009, 15:5165-5175.
81. Ayatollahi M., Soleimani M., Tabei S.Z., et al. Hepatogenic differentiation of mesenchymal stem cells induced by insulin like growth factor-I. World J Stem Cells 2011, 3:113-121.
82. van Poll D., Parekkadan B., Cho C.H., et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008, 47:1634-1643.
83. Kuo T.K., Hung S.P., Chuang C.H., et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008, 134:2111-2121.
84. Sun C.K., Chang C.L., Lin Y.C., et al. Systemic administration of autologous adipose-derived mesenchymal stem cells alleviates hepatic ischemia-reperfusion injury in rats. Crit Care Med 2012, 40:1279-1290.
85. Zhao W., Li J.J., Cao D.Y., et al. Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis. World J Gastroenterol 2012, 18:1048-1058.
86. Saito T., Okumoto K., Haga H., et al. Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev 2011, 20:1503-1510.
87. Lyra A.C., Soares M.B., da Silva L.F., et al. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol 2010, 22:33-42.
88. Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008, 8:726-736.
89. English K., French A., Wood K.J. Mesenchymal stromal cells: facilitators of successful transplantation?. Cell Stem Cell 2010, 7:431-442.
90. Glennie S., Soeiro I., Dyson P.J., et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005, 105:2821-2827.
91. Morandi F., Raffaghello L., Bianchi G., et al. Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens. Stem Cells 2008, 26:1275-1278.
92. Tasso R., Ilengo C., Quarto R., et al. Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 2012, 53:786-793.
93. Nie Y., Lau C.S., Lie A.K., et al. Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 2010, 19:850-859.
94. Sun L.Y., Zhang H.Y., Feng X.B., et al. Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 2007, 16:121-128.
95. Zhou K., Zhang H., Jin O., et al. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol Immunol 2008, 5:417-424.
96. Sun L., Akiyama K., Zhang H., et al. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 2009, 27:1421-1432.
97. Liang J., Zhang H., Hua B., et al. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 2010, 69:1423-1429.
98. Shi D., Wang D., Li X., et al. Allogeneic transplantation of umbilical cord-derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic lupus erythematosus. Clin Rheumatol 2012, 31:841-846.
99. Firestein G.S. Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. J Clin Rheumatol 2005, 11:S39-S44.
100. Zhou B., Yuan J., Zhou Y., et al. Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis. Clin Immunol 2011, 141:328-337.
101. Liu Y., Mu R., Wang S., et al. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther 2010, 12:R210.
102. Park M.J., Park H.S., Cho M.L., et al. Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis. Arthritis Rheum 2011, 63:1668-1680.
103. Liang J., Li X., Zhang H., et al. Allogeneic mesenchymal stem cells transplantation in patients with refractory RA. Clin Rheumatol 2012, 31:157-161.
104. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747.
105. Martin R., McFarland H.F., McFarlin D.E. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992, 10:153-187.
106. Zappia E., Casazza S., Pedemonte E., et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005, 106:1755-1761.
107. Zhang J., Li Y., Chen J., et al. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 2005, 195:16-26.
108. Gerdoni E., Gallo B., Casazza S., et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 2007, 61:219-227.
109. Gordon D., Pavlovska G., Glover C.P., et al. Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration. Neurosci Lett 2008, 448:71-73.
110. Bai L., Lennon D.P., Eaton V., et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009, 57:1192-1203.
111. Rafei M., Birman E., Forner K., et al. Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. Mol Ther 2009, 17:1799-1803.
112. Mohyeddin Bonab M., Yazdanbakhsh S., Lotfi J., et al. Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study. Iran J Immunol 2007, 4:50-57.
113. Yamout B., Hourani R., Salti H., et al. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. J Neuroimmunol 2010, 227:185-189.
114. Wojtovich A.P., Nadtochiy S.M., Brookes P.S., et al. Ischemic preconditioning: the role of mitochondria and aging. Exp Gerontol 2012, 47:1-7.
115. Manogue M., Martin D.M. Changes in patient age and tooth distribution for root canal treatment in a teaching hospital over a 15-year period. Int Endod J 1994, 27:148-153.
116. Conboy I.M., Rando T.A. Aging, stem cells and tissue regeneration. Cell Cycle 2005, 4:407-410.
117. Tuljapurkar S.R., McGuire T.R., Brusnahan S.K., et al. Changes in human bone marrow fat content associated with changes in hematopoietic stem cell numbers and cytokine levels with aging. J Anat 2011, 219:574-581.
118. Morse D. Age-related changes of the dental pulp complex and their relationship to systemic aging. Oral Surg Oral Med Oral Pathol 1991, 72:721-745.
119. Wilson A., Shehadeh L.A., Yu H., et al. Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells. BMC Genomics 2010, 11:229.
120. Yu J.M., Wu X., Gimble J.M., et al. Age-related changes in mesenchymal stem cells derived from rhesus macaque bone marrow. Aging Cell 2011, 10:66-79.
121. Kang M.K., Bibb C., Baluda M.A., et al. In vitro replication and differentiation of normal human oral keratinocytes. Exp Cell Res 2000, 258:288-297.
122. Park I.K., Morrison S.J., Clarke M.F. Bmi1, stem cells, and senescence regulation. J Clin Invest 2004, 113:175-179.
123. Ankrum J., Karp J.M. Mesenchymal stem cell therapy: two steps forward, one step back. Trends Mol Med 2010, 16:203-209.
124. Hussain I., Magd S.A., Eremin O., et al. New approach for isolation of mesenchymal stem cells (MSCs) from human umbilical cord blood. Cell Biol Int 2012, 36:595-600.
125. Hare J.M., Traverse J.H., Henry T.D., et al. Randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchumal stem cells (Prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009, 54:2277-2286.
126. Barry F.P., Murphy J.M., English K., et al. Immunogencity of adult mesenchymal stem cells: lessons from the fetal allograft. Stem Cells Dev 2005, 14:252-265.
127. Lee R.H., Pulin A.A., Seo M.J., et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009, 5:54-63.
128. Meyer J.R. Human embryonic stem cells and respect for life. J Med Ethics 2000, 26:166-170.
129. Griffin M.D., Ritter T., Mahon B.P. Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum Gene Ther 2010, 21:1641-1655.
130. Eliopoulos N., Stagg J., Lejeune L., et al. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 2005, 106:4057-4065.
131. Schu S., Nosov M., O'Flynn L., et al. Immunogenicity of allogeneic mesenchymal stem cells. J Cell Mol Med 2011, [Epub ahead of print].
132. He Q., Li J., Bettiol E., et al. Embryonic stem cells: new possible therapy for degenerative diseases that affect elderly people. J Gerontol A Biol Sci Med Sci 2003, 58:279-287.
133. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast culture by defined factors. Cell 2006, 126:663-676.
134. Yamashita T., Kawai H., Tian F., et al. Tumorigenic development of induced pluripotent stem cells in ischemic mouse brain. Cell Transplant 2011, 20:883-891.
135. Griscelli F., Feraud O., Oudrhiri N., et al. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells. Am J Pathol 2012, 180:2084-2096.
136. Nakamura M., Tokura Y. Epithelial-mesenchymal transition in skin. J Dermatol Sci 2011, 61:7-13.
137. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119:1420-1428.
138. Squier C.A., Kremer M.J. Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr 2001, 29:7-15.
139. Sharav Y., Massler M. Age changes in oral epithelia. Progenitor population, synthesis index and tissue turnover. Exp Cell Res 1967, 47:132-138.
140. Shi S., Bartold P.M., Miura M., et al. The efficacy of mesenchymal stem cells to regenerate and repair dental structures. Orthod Craniofac Res 2005, 8:191-199.
141. Sekiya I., Larson B.L., Vuoristo J.T., et al. Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs). J Bone Miner Res 2004, 19:256-264.
142. Bertani N., Malatesta P., Volpi G., et al. Neurogenic potential of mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray. J Cell Sci 2005, 118:3925-3936.
143. Bosnakovski D., Mizuno M., Kim G., et al. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells in pellet cultural system. Exp Hematol 2004, 32:502-509.
144. Shih D.T., Lee D.C., Chen S.C., et al. Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells 2005, 23:1012-1020.